{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:35:38Z","timestamp":1760985338158},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.parkreldis.2015.08.029","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T22:12:10Z","timestamp":1440540730000},"page":"1232-1237","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Normal substantia nigra patients treated with levodopa \u2013 Clinical, therapeutic and pathological observations"],"prefix":"10.1016","volume":"21","author":[{"given":"Ali H.","family":"Rajput","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele L.","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2015.08.029_bib1","first-page":"124","article-title":"The Pathology of Parkinsonism","volume":"2","author":"Jellinger","year":"1987"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/WNL.0b013e3181ae7af1","article-title":"Course in Parkinson's disease subtypes: a 39-year clinicopathological study","volume":"73","author":"Rajput","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib4","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/mds.21710","article-title":"Accuracy of DaTscan (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-Year follow-up of an open-label study","volume":"22","author":"Tolosa","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/mds.21855","article-title":"The Black Stuff and Konstantin Nikolaevich Tretiakoff","volume":"23","author":"Lees","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0317167100031814","article-title":"Accuracy of clinical diagnosis in parkinsonism \u2013 a prospective study","volume":"18","author":"Rajput","year":"1991","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","article-title":"Low clinical diagnostic accuracy of early vs advanced Parkinson disdease: a clinicopathologic study","volume":"83","author":"Adler","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/01.WNL.0000115145.18830.1A","article-title":"Essential tremor course and disability: a clinicopathological study of 20 cases","volume":"62","author":"Rajput","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib10","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/mds.21159","article-title":"Successful antiparkinsonian medication withdrawal in patients with parkinsonism and normal FP-CIT SPECT","volume":"21","author":"Marshall","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/mds.21505","article-title":"Role of DAT-SPECT in the diagnostic work up of parkinsonism","volume":"22","author":"Scherfler","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/01.WNL.0000078887.16593.12","article-title":"Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome","volume":"61","author":"Connor","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ana.410350405","article-title":"Dopa-responsive dystonia: pathological and biochemical observations in a case","volume":"35","author":"Rajput","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1017\/cjn.2015.13","article-title":"Saskatchewan movement disorders program","volume":"42","author":"Rajput","year":"2015","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00002826-199012000-00007","article-title":"Levodopa efficacy and pathological basis of Parkinson syndrome","volume":"13","author":"Rajput","year":"1990","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib16","first-page":"257","article-title":"Critical analysis of disability in Parkinson's disease","volume":"5","author":"Webster","year":"1968","journal-title":"Mod. Treat."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib17","series-title":"Recent Developments in Parkinson's Disease","first-page":"153","article-title":"UPDRS development committee. Unified Parkinson's disease rating scale","author":"Fahn","year":"1987"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.31.2.125","article-title":"Evidence to support early levodopa therapy in Parkinson disease","volume":"31","author":"Markham","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib20","first-page":"175","article-title":"The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem","volume":"vol. 5","author":"Alvord","year":"1974"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Aging and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/archneur.1982.00510220042009","article-title":"Reversible drug-induced parkinsonism: clinicopathologic study of two cases","volume":"39","author":"Rajput","year":"1982","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.54.1.30","article-title":"The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method","volume":"54","author":"Pakkenberg","year":"1991","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s13311-010-0007-z","article-title":"Neuroimaging in Parkinson's disease","volume":"8","author":"Stoessl","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/mds.23679","article-title":"Milestones in neuroimaging","volume":"26","author":"Stoessl","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000149403.14458.7F","article-title":"The role of radiotracer imaging in Parkinson disease","volume":"64","author":"Ravina","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.23798","article-title":"Validation of nigrostriatal positron emission tomography measures: critical limits","volume":"73","author":"Karimi","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib28","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/mds.25364","article-title":"Factors predictive of the development of levodopa-induced dyskinesias and wearing-off in Parkinson's disease","volume":"28","author":"Olanow","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1212\/WNL.34.8.991","article-title":"Chronic low dose therapy in Parkinson's disease: an argument for delaying levodopa therapy","volume":"34","author":"Rajput","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mds.10031","article-title":"Clinical-pathological study of levodopa complications","volume":"17","author":"Rajput","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrn2471","article-title":"Molecular mechanisms of L-DOPA-induced dyskinesia","volume":"9","author":"Jenner","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mds.870010109","article-title":"Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period","volume":"1","author":"Quinn","year":"1986","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib34","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.870120503","article-title":"Is levodopa toxic to human substantia nigra?","volume":"12","author":"Rajput","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2015.08.029_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.35.4.571","article-title":"Motor function in the normal aging population: treatment with levodopa","volume":"35","author":"Newman","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib36","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/brain\/awp125","article-title":"Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome","volume":"132","author":"Connor","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2015.08.029_bib37","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1212\/WNL.0b013e318232ab4c","article-title":"Does levodopa accelerate the pathologic process in Parkinson disease brain?","volume":"77","author":"Parkkinen","year":"2011","journal-title":"Neurology"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015003685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802015003685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T01:20:33Z","timestamp":1537406433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802015003685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1353802015003685"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.029","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normal substantia nigra patients treated with levodopa \u2013 Clinical, therapeutic and pathological observations","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}